Estimating age-specific cumulative incidence for the 2009 influenza pandemic: A meta-analysis of A(H1N1)pdm09 serological studies from 19 countries

Influenza and other Respiratory Viruses

Volumn 7, Issue 5, 2013, Pages 872-886

  Van Kerkhove, Maria D ^a,b   Hirve, Siddhivinayak ^a   Koukounari, Artemis ^b   Mounts, Anthony W ^a   Allwinn, Regina ^c   Bandaranayake, D Don ^d   Bella, A Antonino ^e   Bone, Angie ^f,al   Carrat, Fabrice ^g   Chadha, Mandeep S ^h   Chen, Mark ⁱ   Chi, Chia Yu ^j   Cox, C M Chad M ^k   Cretikos, Michelle ^l   Crowcroft, Natasha ^m,am,an   Cutter, Jeffery ⁿ   Donnelly, Christl A ^b   de Lamballerie, Xavier ^o   Dellagi, K Koussay ^p   Doukas, George ^q   Dudareva Vizule, Sandra ^r   Ferguson, Neil M ^b   Fry, Alicia M ^k   Gilbert, Gwendolyn L ^s   Haas, Walter ^r   Hardelid, Pia ^t   Horby, Peter ^u   Huang, Q Sue ^d   Hungnes, Olav ^v   Ikonen, Niina ^w   Iwatsuki Horimoto, Kyoko ^x   Julkunen, Iikka ^w   Katz, Jacqueline ^k   Kawaoka, Yoshi ^x   Lalvani, Ajit ^y   Levy Bruhl, Daniel ^f   Maltezou, Helena C ^z   McVernon, Jodie ^aa   Miller, Elizabeth ^t   Mishra, A C ^h   Moghadami, Mohsen ^ab   Pawar, Shailesh D ^h   Reed, Carrie ^k   Riley, Steven ^b   Rizzo, Caterina ^e   Rosella, Laura ^m   Ross, Ted M ^ac   Shu, Yuelong ^ad   Skowronski, Danuta M ^ae   Sridhar, Saranya ^y   Steens, Anneke ^af   Tandale, Babasaheb V ^h   Theodoridou, Maria ^ag   van Boven, Michiel ^ah   Waalen, Kristian ^v   Wang, Jen Ren ^ai   Wu, Joseph T ^aj   Xu, Cuiling ^ad   Zimmer, Shanta ^ak   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f INSTITUT DE VEILLE SANITAIRE   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h NATIONAL INSTITUTE OF VIROLOGY   (India)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^k NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^l Centre for Population Health   (Australia)

^m PUBLIC HEALTH ONTARIO   (Canada)

ⁿ MINISTRY OF HEALTH   (Singapore)

^o AIX MARSEILLE UNIVERSITY   (France)

^p Centre de Recherche et de Veille sur les maladies émergentes dans l'Ocean Indien CRVOI Plateforme de recherche CYROI   (France)

^q CENTRE FOR EPIDEMIOLOGY AND RESEARCH   (Australia)

^r ROBERT KOCH INSTITUTE   (Germany)

^s UNIVERSITY OF SYDNEY   (Australia)

^t PUBLIC HEALTH ENGLAND   (United Kingdom)

^u OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^v NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^w NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^x THE UNIVERSITY OF TOKYO   (Japan)

^y NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^z Hellenic Center for Disease Control and Prevention   (Greece)

^aa UNIVERSITY OF MELBOURNE   (Australia)

^ab SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ac UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^ad National Institute for Viral Disease Control and Prevention   (China)

^ae BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^af Folkehelseinstituttet (FHI)   (Norway)

^ag UNIVERSITY OF ATHENS   (Greece)

^ah NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ai NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^aj UNIVERSITY OF HONG KONG   (Hong Kong)

^ak UNIVERSITY OF PITTSBURGH   (United States)

^al ECDC   (Sweden)

^am UNIVERSITY OF TORONTO   (Canada)

^an UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

A(H1N1)pdm09; Cross reactive antibodies; Cumulative incidence; H1N1pdm; Seroprevalence

Indexed keywords

CROSS REACTING ANTIBODY;

2009 H1N1 INFLUENZA; HEMAGGLUTINATION INHIBITION; HUMAN; INCIDENCE; INFLUENZA VIRUS A H1N1; META ANALYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRUS STRAIN;

A(H1N1)PDM09; CROSS-REACTIVE ANTIBODIES; CUMULATIVE INCIDENCE; H1N1PDM; SEROPREVALENCE;

AGE FACTORS; ANTIBODIES, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 84876180604     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12074     Document Type: Review

References (70)

1. Dawood FS, Iuliano AD, Reed C et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012; 12:687-695.
2. WHO. Summary of WHO technical consultation: H1N1pdm mortality estimates, 2011, 25-26 October 2011. Available at http://www.who.int/influenza/publications/surveillance_monitoring/H1N1pdmMortalityEstimates_WHOconsultation.pdf (Accessed 1 June 2012).
3. WHO. Influenza-like illness in the United States and Mexico, 2009. Available at http://www.who.int/csr/don/2009_04_24/en/index.html (Accessed 31 December 2012).
4. WHO. World Health Organization, situation updates - pandemic (H1N1), 2009. Available at http://www.who.int/csr/disease/swineflu/updates/en/index.html (Accessed 31 December 2012).
5. WHO. Human infection with pandemic (H1N1), 2009 virus: updated interim WHO guidance on global surveillance, 2009. Available at http://www.who.int/csr/resources/publications/swineflu/interim_guidance/en/index.html. World Health Organization. 10 July 2009.
6. WHO. H1N1 in post-pandemic period, 2010. Director-General's opening statement at virtual press conference, 10 August 2010. Available at http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html.
7. WHO. World Health Organization. Situation update pandemic (H1N1), 2009 - update 112, 2010. Available at: http://www.who.int/csr/don/2010_08_06/en/index.html (Accessed 31 December 2012).
8. Wu JT, Ho A, Ma ES et al. Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med 2011; 8:e1001103. Epub 2011 Oct 4.
9. Wu JT, Ma ES, Lee CK et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010; 51:1184-1191.
10. Van Kerkhove MD, Asikainen T, Becker NG et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med 2010; 7:e1000275.
11. Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC, 2009 H1N1 Surveillance Group. Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror 2011; 9:89-115.
12. WHO. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2010; 24:229-236.
13. CDC. 2009 Pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep 2009; 58:913-918.
14. Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361:2619-2627.
15. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324:1557-1561.
16. Laurie KL, Huston P, Riley S et al. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses 2012; doi: 10.1111/j.1750-2659.2012.0370a.x.
17. Kelly H, Peck HA, Laurie KL, Wu P, Nishiura H, Cowling BJ. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS ONE 2011; 6:e21828.
18. WHO. FLUNET the reporting tool of the global influenza surveillance network, 2010. Available at http://www.who.int/influenza/gisrs_laboratory/flunet/en/ (Accessed 31 December 2012).
19. Van Kerkhove MD, Vandemaele KAH, Shinde V et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011; 8:e1001053.
20. United Nations. United Nations Population Division. World population prospects: the 2010 revision, 2010. Available at http://esa.un.org/unpd/wpp/unpp/panel_indicators.htm (Accessed 24 January 2012).
21. The World Bank. Population density (people per sq. km of land area), 2011. Available at http://data.worldbank.org/indicator/EN.POP.DNST (Accessed 24 January 2012).
22. Achonu C, Rosella L, Gubbay JB et al. Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS ONE 2011; 6:e26427.
23. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr H. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 2010; 199:117-121.
24. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 2010; 5:e12562.
25. Ikonen N, Strengell M, Kinnunen L et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010; 15:pii: 19478.
26. Rizzo C, Rota MC, Bella A et al. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010; 28:3558-3562.
27. Skowronski DM, Hottes TS, McElhaney JE et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 2011; 203:158-167.
28. Tandale B, Pawar S, Gurav Y et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 2010; 10:255.
29. Bandaranayake D, Huang QS, Bissielo A, Wood T. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand, 2010. In: ESR, ed. Available at http://www.health.govt.nz/publication/seroprevalence-2009-influenza-h1n1-pandemic-new-zealand (Accessed 7 January 2013).
30. Bone A, Guthmann J-P, Assal A et al. Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS ONE 2012; 7:e33056.
31. Dudareva S, Schweiger B, Thamm M et al. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS ONE 2011; 6:e21340.
32. Iwatsuki-Horimoto K, Horimoto T, Tamura D et al. Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin Vaccine Immunol 2011; 18:860-866.
33. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:1100-1108.
34. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hungnes O. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 2010; 15:pii=19633. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19633.
35. Xu C, Bai T, Iuliano AD et al. The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS ONE 2011; 6:e17919.
36. Chen M, Lee VJ, Lim WY et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010; 303:1383-1391.
37. Dellagi K, Rollot O, Temmam S et al. Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, Austral Winter 2009. PLoS ONE 2011; 6:e25738.
38. McVernon J, Laurie K, Nolan T et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill 2010; 15:pii=19678. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19678.
39. Reed C, Katz JM, Hancock K, Balish A, Fry AM, for the H1N1 Serosurvey Working Group. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic. PLoS One. 2012; 7:e48187.
40. Soh SE, Cook AR, Chen MIC et al. Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore. BMC Infect Dis 2012; 12:336.
41. Hardelid P, Andrews N, Hoschler K et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A H1N1 2009. Health Technol Assess 2010; 14:115-192.
42. Horby P, Mai LQ, Fox A et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam Household Cohort Study I. Am J Epidemiol 2012; 175:1062-1074.
43. Wu JT, Ma ES, Lee CK et al. A serial cross-sectional serologic survey of 2009 Pandemic (H1N1) in Hong Kong: implications for future pandemic influenza surveillance. Influenza Other Respi Viruses 2011; 5(Suppl. 1):190-194.
44. Cox C, Goodin K, Fisher E et al. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida - November-December, 2009. PLoS ONE 2011; 6:e29301.
45. Lapidus N, de Lamballerie X, Salez N et al. Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC Public Health 2012; 12:417.
46. Moghadami M, Moattari A, Tabatabaee HR et al. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran. Iran J Immunol 2010; 7:39-48.
47. Skowronski DM, Hottes TS, Janjua NZ et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010; 182:1851-1856.
48. Steens A, Waaijenborg S, Teunis PFM et al. Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): evidence from serial serologic surveys in the Netherlands. Am J Epidemiol 2011; 174:1307-1315, Epub 2011 Oct 24.
49. Zimmer SM, Crevar CJ, Carter DM et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 2010; 5:e11601.
50. Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 2010; 5:e13211.
51. Maltezou HC, Katerelos P, Mavrouli M et al. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 2011; 29:6664-6669.
52. Chi C-Y, Liu C-C, Lin C-C et al. Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population. Clin Vaccine Immunol 2010; 17:1958-1962.
53. Sigmundsdottir G, Gudnason T, Ólafsson Ö et al. Surveillance of influenza in Iceland during the 2009 pandemic. Euro Surveill 2010; 15:pii: 19742.
54. Elizondo-Montemayor L, Alvarez MM, Hernández-Torre M et al. Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method. Int J Infect Dis 2011; 15:e781-e786.
55. Kode SS, Pawar SD, Tandale BV, Parkhi SS, Barde TD, Mishra AC. Low level of cross-reactive antibodies to pandemic influenza (H1N1) 2009 virus in humans in pre-pandemic period in Maharashtra, India. Indian J Virol 2012; 23:36-38.
56. Burmaa A, Tsatsral S, Odagiri T, Suzuki A, Oshitani H, Nymadawa P. Seroconversion rates of Pandemic Influenza A (H1N1) 2009 by a community-based cohort study in Selenghe Province, Mongolia. Influenza Other Respi Viruses 2012; doi: 10.1111/j.1750-2659.2012.00334.x.
57. Riley S, Kwok KO, Wu KM et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011; 8:e1000442.
58. Cowling BJ, Chan KH, Fang VJ et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
59. Papenburg J, Baz M, Hamelin M-E et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 2010; 51:1033-1041.
60. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
61. Verma N, Dimitrova M, Carter DM et al. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. J Virol 2012; 86:5515-5522. Epub 2012 Feb 29.
62. Stephenson I, Heath A, Major D et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009; 15:1252-1259.
63. Broberg E, Nicoll A, Amato-Gauci A. Seroprevalence to influenza A(H1N1) 2009 virus where are we? Clin Vaccine Immunol 2011; 18:1205-1212.
64. Chen MI, Barr IG, Koh GCH et al. Serological response in RT-PCR confirmed H1N1-2009 influenza A by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS ONE 2010; 5:e12474.
65. Veguilla V, Hancock K, Schiffer J et al. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 2011; 49:2210-2215. Epub 2011 Apr 6. 2011.
66. Esposito S, Daleno C, Tagliabue C et al. Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. Virol J 2011; 8:563.
67. Delangue J, Salez N, Ninove L et al. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clin Microbiol Infect 2012; 18:177-183.
68. Van Kerkhove MD, Mounts AW. 2009 Versus 2010 comparison of influenza activity in southern hemisphere temperate countries. Influenza Other Respi Viruses 2011; 5:375-379.
69. Van Kerkhove MD, Mounts AW, Mall S et al. Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza Other Respi Viruses 2011; 5:e487-e498.
70. Koita OA, Sangare L, Poudiougou B et al. A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali. Clin Microbiol Infect 2012; 18:976-981.